Clinical Trials Browser

Phase NA × Completed × infigratinib × Clear all

NCT02657486 2026-02-09

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Phase NA Completed

Urinary Bladder Neoplasms